Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anecdotal evidence is everywhere in healthcare, it does not tell you much. Generic drugs have different fillers and dyes, so sometimes look and taste different. I have no doubt seek is telling his true experience, but chem analysis is the only way to know.
If a guy tells you he is eating dirt and his arthritis is gone, you are probably not going to start eating dirt.
db
Ten days, zero side effects, the jury is still out on efficacy.
Hoping for the best, would love to see side by side gas chromatography.
Watching here for someone to test it in a lab.
My guess is it is shorts closing positions for almost nothing.
db
Yeah, F the planet.
db
If I remember correctly, it was in one of the announcements of the sale. Pretty sure, I believe it was 2% of production after expenses. Not sure of the wording but 2% sticks. One of the reasons I stayed around.
db
I believe the answer to #4 is 2%. Got some at .003. What the heck.
db
That author needs to take a statistics class. The larger the sample the less likely random events have an affect, so a smaller percentage difference between groups is significant. Pretty basic idea.
I still have questions about the change but that author's opinion is less than helpful. And it seems to me that many of these small investment info sites have an agenda.
IMO,
db
Sounds like "only I can fix it"
db
Not really. It would make bankruptcy more likely.
db
One of the things wrong with this format is the spin doctors that show up. Zero followers, new persona, multiple post on one board, throw in a little truth and then lie about the things people don't check.
Management had significant positions in the form of stock options and purchased stock prior to the split.
db
Company officers and particularly the CEO have been awarded stock and options at much higher prices which are worth almost nothing now. They made some clearly damaging decisions, but I do not think they acted in bad faith. They believe in Anatabine and have lost more than most long term stock holders.
db
Ha ha,
I don't have an answer for you. If it is any comfort I am in the same boat, and using the same strategy. Bought more this am and will buy more if it makes new lows.
db
Yes, for less than we paid for the stock alone. If you get someone to underwrite my investments I will agree we should underwrite theirs.
LOL,
db
Ha ha,
This is the oil business. I am hard pressed to remember any project where dates have not slipped.
The rig is up, probably running, not really concerned about a week or two.
Just more noise as usual.
And their most recent said "near".
Noise about nothing.
db
They said near the end of Q1.
Thanks,
Many here are interested in inflammation. Feel free to post results here if you have time.
db
Wading through message boards can be annoying, but posts like yours make it worthwhile.
Thanks for the info, excellent blog.
db
Yup, no way they drill deep water now. HDYN's only hope is an arbitration or suit settlement for compensation. That "better managed company" is probably screwed. Maybe Tullow will buy them out to avoid a settlement. Long long shot.
HA ha, should have bought more ERHE.
db
Thanks leifsmith,
Looks like the VA may provide an end run around the FDA. Or at least a push in the right direction.
Hope it helps these guys.
db
Scottrade, Schwab, Ameritrade all not converted yet.
db
Nope,
Yet another drug aimed at one autoimmune disease that shows promise for another one. The problem of course is side effects. Embryl, prednisone, methotrexate, etc all have serious sight threatening or life threatening side effects. My guess is this one will also.
Rheumatologists exist because these drugs have inherent dangers and most doctors are not willing to prescribe them long term if a specialist is available. Most will prescribe prednisone, but are aware of the potential for cataracts and glaucoma and require frequent eye checks.
It will take time for approval, but i think Anatabine citrate will stop or alleviate or delay many of these diseases without side effects. It has been said before, but for my generation I think this is on the order of the discovery of penicillin.
Oh wait, the FDA has to protect us first.
db
Contrary to some opinions here it looks to me like management has done a superb job of surviving in very tough times to give us another shot at a big gain. Kudos.
db
It is true!
Some people go through life without any idea of how the rest of the world views them.
Probably a merciful ignorance.
My my....
db
Proportional
db
Geert owns over eight million shares.
db
The psoriasis studies in Europe are oral doses in various amounts. My impression and the company has stated that this application is probably the quickest way to approval for a new drug. Real effects can be seen in very short periods of time. The "anecdotal" accounts of reduction in plaque psoriasis are extremely numerous. I personally know of two people who started and stopped Anatabloc for several months each, wondering if their results were coincidental. They both saw a return to a higher level of disease and a subsequent lapse when they restarted AB.
Neither saw an end to psoriasis, but both saw a significant reduction with AB, and a return to preexisting levels with out AB.
I take AB as a possible preventative to the AZ in my family. My C reactive protein went to normal levels and has stayed there since starting. I have read all the studies and am convinced of the efficacy. Whether or not this company makes us money will depend on management, but the drug is a potential block buster.
As soon as an oral version is available it will be used off label by me and others. The problem is we are looking at a bureaucratic nightmare. The FDA has become a manipulated tool of the major drug makers in my opinion. The ghost of Thalidomide hovers over the institution, making the approval process expensive and time consuming, all the while employees going back and forth between government and industry, never mind the conflicts.
Barring some fast track miracle, we won't see AB on the market til 2020-21, and then it will be for the least life threatening application.
IMO, db
Me too, Absolutely. This has always been a risky bet, but voting against at this point is just plain... well, you know. Tie management's hands when they may need the reverse to honor owed shares risks bankruptcy.
Then it is too late to change your mind, and risk is reduced to zero because your investment is worthless. I'm staying with management.
Protest at your own risk.
db
You should quit putting your hand on the stove.
Db
Ha ha,
I had posts removed from his "moderated" board for disagreeing with him. He uses a range of personalities and aliases on different boards, often disagreeable and wrong. Watched his diatribes for maybe fifteen years, I am not likely to leave his pronouncements unchecked.
db
May be why he left his position has and oil company accountant
Db
And me.
db
Ignore the nattering nabobs of negativism.
I AM one with Ntephe...OOOOOOMMMMMMMMM....
DB
Yup, me too.
By Easter? Could be. And if we hit oil it could just be the start. Assets/market cap. Ridiculous now, but will move toward each other.
db
It may have been available, but I had not read of a trial design. One of my concerns was that they might have been aiming at a topical cream or ointment. Oral dosing is the key to the anti inflammatory disease world, because approval for psoriasis will lead quickly to off label use by many previous over the counter users, IE me and many across the country.
The safety profile will make it easy for Doctors to try it for many currently intractable problems.
I might even go to England for an Rx.
In the world of regulatory approval the short length of the phases will make this relatively quick. May not move the stock, but this is very good news to me.
db
Ha ha,
Can't you tell? Pretty simple math.
Hey Julius,
Nice post, well thought out. I agree with the people around you.
db
Hey!
Maybe you can finally get even!
db
Ha ha,
From a MODERATED discussion on HDYN,
"Frustrated
It seem like the only thing going on with this company is the corporate officers collecting paychecks for doing nothing ... Really WTF? Time for a change in management ... The only thing Ray has managed to do is get de-listed"
Gotta love the trolls
db
The difference I see is that ERHC managed to survive and give us a second shot soon, and perhaps more after that. Better management than the ones that fail.
db
Gonna hafta bookmark Bubba.....
db